925441-35-6 Usage
Uses
Used in Pharmaceutical Industry:
2,6-DIMETHYL-4-FLUOROBENZALDEHYDE is used as a chemical intermediate for the synthesis of various pharmaceuticals, contributing to the development of new drugs and medications. Its unique chemical structure allows it to be a key component in the production of therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical sector, 2,6-DIMETHYL-4-FLUOROBENZALDEHYDE is utilized as an intermediate in the synthesis of agrochemicals, such as pesticides and herbicides. Its role in these applications helps to improve agricultural productivity and crop protection.
Used in Fragrance Industry:
2,6-DIMETHYL-4-FLUOROBENZALDEHYDE is used as a fragrance ingredient in various consumer products, including perfumes, cosmetics, and personal care items. Its distinctive aroma adds a unique scent profile to these products, enhancing their appeal to consumers.
Used in Flavor Industry:
This chemical compound is also employed as a flavoring agent in the food and beverage industry. Its distinctive taste and aroma contribute to the flavor profiles of various products, providing a unique sensory experience for consumers.
Check Digit Verification of cas no
The CAS Registry Mumber 925441-35-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,5,4,4 and 1 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 925441-35:
(8*9)+(7*2)+(6*5)+(5*4)+(4*4)+(3*1)+(2*3)+(1*5)=166
166 % 10 = 6
So 925441-35-6 is a valid CAS Registry Number.
925441-35-6Relevant academic research and scientific papers
Yokota, Sawako,Fujii, Hiroshi
, p. 5127 - 5137 (2018)
Heterolytic versus homolytic cleavage of the metal-bound terminal oxidant is the key for determining the nature of reactive intermediates in metalloenzymes and metal catalyzed oxygenation reactions. Here, we study the bond cleavage process of hypochlorite
COMPOUNDS, COMPOSITIONS AND METHODS FOR HISTONE LYSINE DEMETHYLASE INHIBITION
-
Paragraph 0737; 0789, (2022/03/09)
The present disclosure relates generally to compounds and pharmaceutical compositions for the selective inhibition of histone lysine demethylase5 (KDM5), particularly KDM5B, and methods of their use in treating conditions and diseases associated with KDM5 activity.
